Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Placenta Accreta | 16 | 2023 | 241 | 4.080 |
Why?
|
Placenta | 30 | 2024 | 1722 | 3.950 |
Why?
|
Endometrial Neoplasms | 23 | 2021 | 1382 | 3.320 |
Why?
|
Carcinoma, Endometrioid | 11 | 2020 | 276 | 1.850 |
Why?
|
Ovarian Neoplasms | 34 | 2024 | 4908 | 1.640 |
Why?
|
Adenocarcinoma, Clear Cell | 11 | 2019 | 218 | 1.590 |
Why?
|
Endometrial Hyperplasia | 5 | 2021 | 99 | 1.390 |
Why?
|
Placentation | 2 | 2020 | 78 | 1.230 |
Why?
|
Fallopian Tube Neoplasms | 5 | 2020 | 329 | 1.200 |
Why?
|
Postpartum Hemorrhage | 4 | 2024 | 273 | 1.150 |
Why?
|
Cystadenocarcinoma, Serous | 7 | 2022 | 480 | 1.100 |
Why?
|
Precancerous Conditions | 7 | 2020 | 984 | 1.100 |
Why?
|
Carcinoma in Situ | 4 | 2020 | 789 | 1.060 |
Why?
|
Hysterectomy | 7 | 2022 | 863 | 1.040 |
Why?
|
Chorioamnionitis | 7 | 2020 | 156 | 1.020 |
Why?
|
Endometrium | 6 | 2021 | 407 | 0.970 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 3 | 2017 | 560 | 0.970 |
Why?
|
Placenta Diseases | 7 | 2024 | 199 | 0.960 |
Why?
|
Adnexal Diseases | 6 | 2019 | 105 | 0.950 |
Why?
|
Placenta Previa | 5 | 2023 | 126 | 0.880 |
Why?
|
Pregnancy | 58 | 2024 | 30198 | 0.820 |
Why?
|
Autopsy | 3 | 2021 | 1013 | 0.760 |
Why?
|
Prenatal Diagnosis | 5 | 2024 | 1274 | 0.740 |
Why?
|
Teratoma | 1 | 2024 | 405 | 0.740 |
Why?
|
Mycobacterium bovis | 1 | 2021 | 148 | 0.720 |
Why?
|
Cysts | 3 | 2021 | 685 | 0.700 |
Why?
|
Placental Insufficiency | 2 | 2017 | 50 | 0.660 |
Why?
|
Fetal Growth Retardation | 6 | 2016 | 591 | 0.650 |
Why?
|
Pathology, Clinical | 2 | 2020 | 376 | 0.610 |
Why?
|
Cervix Uteri | 5 | 2021 | 577 | 0.580 |
Why?
|
Carcinoma | 5 | 2022 | 2340 | 0.580 |
Why?
|
Female | 159 | 2024 | 397050 | 0.580 |
Why?
|
Cesarean Section | 9 | 2023 | 1417 | 0.580 |
Why?
|
Adenocarcinoma | 10 | 2013 | 6404 | 0.570 |
Why?
|
Pre-Eclampsia | 6 | 2017 | 1255 | 0.550 |
Why?
|
Eclampsia | 1 | 2017 | 60 | 0.550 |
Why?
|
Decidua | 1 | 2016 | 82 | 0.510 |
Why?
|
Pregnancy Trimester, Second | 6 | 2024 | 737 | 0.480 |
Why?
|
Infant, Small for Gestational Age | 2 | 2017 | 469 | 0.480 |
Why?
|
Endometritis | 2 | 2021 | 49 | 0.470 |
Why?
|
Obstetric Labor, Premature | 6 | 2014 | 273 | 0.470 |
Why?
|
Medical Records | 1 | 2020 | 1413 | 0.470 |
Why?
|
Uterus | 2 | 2021 | 661 | 0.460 |
Why?
|
Gestational Age | 16 | 2021 | 3615 | 0.450 |
Why?
|
Infant, Premature | 12 | 2022 | 2125 | 0.440 |
Why?
|
Endometriosis | 2 | 2021 | 875 | 0.430 |
Why?
|
Tissue Array Analysis | 4 | 2016 | 551 | 0.430 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2021 | 391 | 0.430 |
Why?
|
Humans | 183 | 2024 | 768298 | 0.430 |
Why?
|
Uterine Neoplasms | 3 | 2020 | 1426 | 0.420 |
Why?
|
Premature Birth | 5 | 2022 | 1814 | 0.420 |
Why?
|
Umbilical Cord | 3 | 2011 | 178 | 0.420 |
Why?
|
Terminology as Topic | 1 | 2020 | 1539 | 0.410 |
Why?
|
Lymph Nodes | 4 | 2019 | 3471 | 0.410 |
Why?
|
Ultrasonography, Prenatal | 8 | 2024 | 1767 | 0.410 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2014 | 308 | 0.400 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1525 | 0.390 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2011 | 13 | 0.390 |
Why?
|
Vascular Diseases | 2 | 2020 | 1161 | 0.390 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2016 | 388 | 0.380 |
Why?
|
Receptors, Progesterone | 3 | 2016 | 1145 | 0.360 |
Why?
|
Amniotic Fluid | 2 | 2011 | 381 | 0.360 |
Why?
|
Down-Regulation | 2 | 2017 | 2937 | 0.350 |
Why?
|
Ovarian Cysts | 3 | 2021 | 108 | 0.350 |
Why?
|
Immunohistochemistry | 17 | 2023 | 11117 | 0.350 |
Why?
|
Estrogen Receptor alpha | 2 | 2016 | 580 | 0.340 |
Why?
|
Lymph Node Excision | 3 | 2019 | 1274 | 0.330 |
Why?
|
Blood Proteins | 3 | 2016 | 1186 | 0.330 |
Why?
|
Mesothelioma | 3 | 2006 | 811 | 0.320 |
Why?
|
Kidney | 3 | 2021 | 7063 | 0.320 |
Why?
|
Integrin alphaV | 1 | 2008 | 54 | 0.320 |
Why?
|
Fallopian Tubes | 3 | 2020 | 179 | 0.310 |
Why?
|
Integrin beta Chains | 1 | 2008 | 115 | 0.310 |
Why?
|
Up-Regulation | 2 | 2017 | 4137 | 0.310 |
Why?
|
Tuberculosis | 1 | 2021 | 2029 | 0.300 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 2007 | 5 | 0.300 |
Why?
|
Observer Variation | 6 | 2019 | 2623 | 0.300 |
Why?
|
Middle Aged | 62 | 2024 | 223463 | 0.300 |
Why?
|
Biopsy | 8 | 2021 | 6808 | 0.290 |
Why?
|
Adult | 64 | 2024 | 223622 | 0.290 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1158 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2021 | 2044 | 0.280 |
Why?
|
Pregnancy, Ectopic | 2 | 2024 | 146 | 0.270 |
Why?
|
Infant, Newborn | 23 | 2023 | 26410 | 0.270 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1180 | 0.260 |
Why?
|
Ovary | 3 | 2013 | 960 | 0.260 |
Why?
|
Fetal Heart | 1 | 2007 | 281 | 0.260 |
Why?
|
Diagnostic Errors | 3 | 2009 | 1280 | 0.250 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2635 | 0.250 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 433 | 0.250 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.250 |
Why?
|
Liver | 2 | 2021 | 7570 | 0.250 |
Why?
|
Epididymal Secretory Proteins | 1 | 2005 | 12 | 0.250 |
Why?
|
Parity | 3 | 2017 | 938 | 0.250 |
Why?
|
Fetal Diseases | 2 | 2007 | 916 | 0.250 |
Why?
|
Uterine Hemorrhage | 1 | 2006 | 240 | 0.240 |
Why?
|
Case-Control Studies | 18 | 2023 | 22292 | 0.240 |
Why?
|
beta Catenin | 2 | 2020 | 1047 | 0.240 |
Why?
|
Menstruation | 1 | 2006 | 310 | 0.240 |
Why?
|
WT1 Proteins | 2 | 2002 | 184 | 0.230 |
Why?
|
Down Syndrome | 5 | 2016 | 915 | 0.230 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2011 | 2185 | 0.230 |
Why?
|
Cell Adhesion Molecules | 5 | 2011 | 1614 | 0.230 |
Why?
|
Chorion | 2 | 2018 | 112 | 0.230 |
Why?
|
Mucin-1 | 3 | 2021 | 538 | 0.220 |
Why?
|
Transcription Factors | 8 | 2024 | 12166 | 0.220 |
Why?
|
Biopsy, Needle | 3 | 2003 | 1627 | 0.220 |
Why?
|
Facies | 1 | 2024 | 224 | 0.220 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2950 | 0.220 |
Why?
|
Neural Stem Cells | 4 | 2018 | 891 | 0.210 |
Why?
|
Fetoscopy | 1 | 2024 | 138 | 0.210 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 13019 | 0.200 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 320 | 0.200 |
Why?
|
Complement Activation | 2 | 2021 | 447 | 0.200 |
Why?
|
Polyps | 1 | 2004 | 200 | 0.200 |
Why?
|
Hydrops Fetalis | 1 | 2022 | 113 | 0.200 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 413 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2006 | 2846 | 0.200 |
Why?
|
Hydatidiform Mole | 1 | 2024 | 255 | 0.190 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2013 | 489 | 0.190 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2024 | 259 | 0.190 |
Why?
|
Pregnancy Proteins | 2 | 2014 | 223 | 0.190 |
Why?
|
Cystadenoma | 1 | 2021 | 77 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 325 | 0.190 |
Why?
|
Aged | 36 | 2024 | 171544 | 0.190 |
Why?
|
Cystadenoma, Mucinous | 1 | 2021 | 62 | 0.190 |
Why?
|
Fibroma | 1 | 2023 | 201 | 0.190 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 2011 | 139 | 0.190 |
Why?
|
Curettage | 2 | 2021 | 74 | 0.190 |
Why?
|
Immunoenzyme Techniques | 5 | 2009 | 1705 | 0.190 |
Why?
|
Myiasis | 1 | 2001 | 14 | 0.190 |
Why?
|
Skin Diseases, Parasitic | 1 | 2001 | 13 | 0.190 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3236 | 0.190 |
Why?
|
Lymphatic Metastasis | 5 | 2013 | 2924 | 0.190 |
Why?
|
Translocation, Genetic | 2 | 2024 | 1395 | 0.190 |
Why?
|
Stromal Cells | 1 | 2006 | 1337 | 0.180 |
Why?
|
Cerebral Palsy | 2 | 2020 | 479 | 0.180 |
Why?
|
Diptera | 1 | 2001 | 50 | 0.180 |
Why?
|
Complement Pathway, Alternative | 1 | 2021 | 113 | 0.180 |
Why?
|
Internet | 2 | 2011 | 3107 | 0.180 |
Why?
|
Cerebral Cortex | 5 | 2018 | 5830 | 0.180 |
Why?
|
PAX2 Transcription Factor | 1 | 2020 | 86 | 0.180 |
Why?
|
Nuclear Proteins | 4 | 2019 | 5802 | 0.180 |
Why?
|
Fetus | 3 | 2018 | 1883 | 0.170 |
Why?
|
Aged, 80 and over | 16 | 2021 | 59683 | 0.170 |
Why?
|
Abortion, Spontaneous | 2 | 2024 | 539 | 0.170 |
Why?
|
Matrix Metalloproteinases | 3 | 2011 | 393 | 0.170 |
Why?
|
Logistic Models | 7 | 2016 | 13323 | 0.170 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3631 | 0.170 |
Why?
|
Postmenopause | 4 | 2021 | 2518 | 0.170 |
Why?
|
Forms and Records Control | 1 | 2020 | 158 | 0.170 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 171 | 0.170 |
Why?
|
Endosonography | 1 | 2003 | 622 | 0.160 |
Why?
|
Obstetrics | 2 | 2023 | 676 | 0.160 |
Why?
|
Microsatellite Instability | 3 | 2020 | 726 | 0.160 |
Why?
|
Endodermal Sinus Tumor | 1 | 2019 | 53 | 0.160 |
Why?
|
S100 Proteins | 2 | 2011 | 217 | 0.160 |
Why?
|
Genital Neoplasms, Female | 2 | 2018 | 538 | 0.160 |
Why?
|
Birth Weight | 1 | 2007 | 2114 | 0.160 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 98 | 0.160 |
Why?
|
DNA Polymerase II | 1 | 2019 | 104 | 0.150 |
Why?
|
Reproducibility of Results | 7 | 2021 | 20224 | 0.150 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 529 | 0.150 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 750 | 0.150 |
Why?
|
BCG Vaccine | 1 | 2021 | 383 | 0.150 |
Why?
|
Sarcoma | 2 | 2020 | 1806 | 0.150 |
Why?
|
Neurons | 8 | 2018 | 9512 | 0.150 |
Why?
|
Burkitt Lymphoma | 1 | 2000 | 337 | 0.150 |
Why?
|
Chemokines | 3 | 2011 | 962 | 0.150 |
Why?
|
Abortion, Induced | 1 | 2024 | 475 | 0.150 |
Why?
|
Complement System Proteins | 1 | 2021 | 738 | 0.150 |
Why?
|
Reproductive History | 2 | 2016 | 210 | 0.150 |
Why?
|
Adrenergic beta-Agonists | 1 | 1999 | 347 | 0.150 |
Why?
|
Pregnancy, Multiple | 2 | 2010 | 216 | 0.150 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11254 | 0.150 |
Why?
|
Infant, Premature, Diseases | 3 | 2014 | 712 | 0.150 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2017 | 44 | 0.150 |
Why?
|
Fibromatosis, Aggressive | 1 | 2019 | 125 | 0.140 |
Why?
|
Nutrition Assessment | 1 | 2021 | 740 | 0.140 |
Why?
|
Bronchial Fistula | 1 | 2018 | 83 | 0.140 |
Why?
|
Chromosomes, Human, Pair 21 | 2 | 2016 | 229 | 0.140 |
Why?
|
Chorionic Villi | 1 | 2017 | 53 | 0.140 |
Why?
|
Amnion | 1 | 2018 | 202 | 0.140 |
Why?
|
Stress Fibers | 1 | 2017 | 55 | 0.140 |
Why?
|
Retrospective Studies | 19 | 2023 | 81768 | 0.140 |
Why?
|
Gastric Fistula | 1 | 2018 | 73 | 0.140 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2012 | 84 | 0.140 |
Why?
|
Language Development | 1 | 2018 | 184 | 0.140 |
Why?
|
Triage | 1 | 2024 | 994 | 0.140 |
Why?
|
Neoplasm Metastasis | 3 | 2004 | 4921 | 0.140 |
Why?
|
Vitamin B 6 | 2 | 2010 | 234 | 0.140 |
Why?
|
Septal Occluder Device | 1 | 2018 | 125 | 0.140 |
Why?
|
Abnormalities, Multiple | 1 | 2024 | 1424 | 0.140 |
Why?
|
Fetal Death | 1 | 2018 | 438 | 0.140 |
Why?
|
Immunocompromised Host | 1 | 2002 | 863 | 0.140 |
Why?
|
Bacteria | 1 | 2008 | 2222 | 0.140 |
Why?
|
RNA, Viral | 2 | 2021 | 2866 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 710 | 0.140 |
Why?
|
Hemoptysis | 1 | 2018 | 152 | 0.140 |
Why?
|
Sodium Channels | 1 | 2018 | 341 | 0.130 |
Why?
|
Nerve Growth Factors | 2 | 2011 | 564 | 0.130 |
Why?
|
Antigens, CD | 3 | 2016 | 4031 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3199 | 0.130 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3940 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1999 | 0.130 |
Why?
|
Gastroscopy | 1 | 2018 | 213 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2005 | 986 | 0.130 |
Why?
|
Vagina | 1 | 2002 | 845 | 0.130 |
Why?
|
Desmin | 1 | 2016 | 99 | 0.130 |
Why?
|
Lung Injury | 1 | 2021 | 433 | 0.130 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 243 | 0.130 |
Why?
|
Microcephaly | 2 | 2010 | 426 | 0.130 |
Why?
|
Hepatocytes | 1 | 2023 | 1245 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 599 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 566 | 0.130 |
Why?
|
Chondrocytes | 3 | 2017 | 800 | 0.130 |
Why?
|
Nerve Tissue Proteins | 3 | 2015 | 4414 | 0.130 |
Why?
|
False Positive Reactions | 2 | 2012 | 962 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 237 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 617 | 0.130 |
Why?
|
Methionine | 2 | 2010 | 573 | 0.130 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15455 | 0.130 |
Why?
|
Rotator Cuff | 1 | 2019 | 349 | 0.130 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2016 | 144 | 0.120 |
Why?
|
MicroRNAs | 2 | 2022 | 3794 | 0.120 |
Why?
|
Kidney Neoplasms | 3 | 2024 | 4301 | 0.120 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2016 | 217 | 0.120 |
Why?
|
Gynecology | 3 | 2021 | 532 | 0.120 |
Why?
|
Cytokines | 5 | 2020 | 7443 | 0.120 |
Why?
|
Endemic Diseases | 2 | 2013 | 190 | 0.120 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 283 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 463 | 0.120 |
Why?
|
Uterine Cervical Diseases | 1 | 1995 | 75 | 0.120 |
Why?
|
Estrogens | 3 | 2023 | 1534 | 0.120 |
Why?
|
Health Maintenance Organizations | 1 | 1997 | 658 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1575 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 196 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 1999 | 577 | 0.110 |
Why?
|
Repressor Proteins | 4 | 2020 | 2986 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 418 | 0.110 |
Why?
|
Ultrasonography | 4 | 2019 | 6001 | 0.110 |
Why?
|
Pregnancy Outcome | 5 | 2018 | 2961 | 0.110 |
Why?
|
DNA Helicases | 1 | 2019 | 853 | 0.110 |
Why?
|
Antigens, CD34 | 1 | 2016 | 656 | 0.110 |
Why?
|
Myocardium | 2 | 2021 | 4788 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2811 | 0.110 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 708 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1166 | 0.110 |
Why?
|
Risk Factors | 19 | 2023 | 74954 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 917 | 0.110 |
Why?
|
Oncogene Proteins, Viral | 1 | 1995 | 342 | 0.110 |
Why?
|
Fibrin | 1 | 2016 | 514 | 0.110 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2013 | 71 | 0.110 |
Why?
|
CDC2 Protein Kinase | 1 | 2014 | 212 | 0.110 |
Why?
|
Proportional Hazards Models | 7 | 2021 | 12557 | 0.100 |
Why?
|
Racemases and Epimerases | 1 | 2013 | 114 | 0.100 |
Why?
|
Chickenpox | 1 | 2013 | 96 | 0.100 |
Why?
|
Myometrium | 1 | 2013 | 174 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Organ Size | 2 | 2008 | 2268 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2771 | 0.100 |
Why?
|
Pregnancy Complications | 3 | 2012 | 2971 | 0.100 |
Why?
|
Clinical Competence | 1 | 2008 | 4847 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8628 | 0.100 |
Why?
|
Mass Vaccination | 1 | 2013 | 110 | 0.100 |
Why?
|
Neoplasm Proteins | 4 | 2024 | 3609 | 0.100 |
Why?
|
Bronchoscopy | 1 | 2018 | 913 | 0.100 |
Why?
|
Stem Cells | 3 | 2011 | 3537 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3136 | 0.100 |
Why?
|
Folic Acid | 2 | 2010 | 1336 | 0.090 |
Why?
|
Stathmin | 1 | 2011 | 70 | 0.090 |
Why?
|
Brain | 2 | 2018 | 27452 | 0.090 |
Why?
|
Peroxidase | 2 | 2011 | 609 | 0.090 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14736 | 0.090 |
Why?
|
Lung | 4 | 2021 | 10087 | 0.090 |
Why?
|
Parvovirus B19, Human | 1 | 2010 | 42 | 0.090 |
Why?
|
Telepathology | 1 | 2011 | 77 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2014 | 993 | 0.090 |
Why?
|
Prospective Studies | 13 | 2023 | 54921 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2011 | 664 | 0.090 |
Why?
|
Papillomaviridae | 2 | 2004 | 1140 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.090 |
Why?
|
Smoking | 5 | 2015 | 9109 | 0.090 |
Why?
|
Diplopia | 1 | 2011 | 217 | 0.090 |
Why?
|
Germ-Line Mutation | 2 | 2019 | 1885 | 0.090 |
Why?
|
Male | 36 | 2024 | 364870 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 1999 | 1812 | 0.080 |
Why?
|
Phenotype | 8 | 2022 | 16716 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2015 | 1141 | 0.080 |
Why?
|
Child Behavior Disorders | 1 | 2014 | 813 | 0.080 |
Why?
|
Twins, Monozygotic | 2 | 2010 | 472 | 0.080 |
Why?
|
Ureaplasma urealyticum | 1 | 2009 | 39 | 0.080 |
Why?
|
Vasculitis | 2 | 2018 | 524 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2014 | 21163 | 0.080 |
Why?
|
Umbilical Veins | 1 | 2010 | 424 | 0.080 |
Why?
|
Ataxia | 1 | 2011 | 307 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5311 | 0.080 |
Why?
|
Asthma | 2 | 1999 | 6281 | 0.080 |
Why?
|
Cleidocranial Dysplasia | 2 | 1999 | 18 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 740 | 0.080 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9508 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3431 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9261 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2277 | 0.080 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2008 | 57 | 0.080 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2011 | 378 | 0.080 |
Why?
|
Vaginal Smears | 2 | 2021 | 505 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1658 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 4 | 2009 | 20766 | 0.080 |
Why?
|
Inflammation | 6 | 2021 | 10863 | 0.080 |
Why?
|
Neurogenesis | 2 | 2012 | 864 | 0.080 |
Why?
|
Neoplasms | 2 | 2011 | 22389 | 0.070 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2533 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 633 | 0.070 |
Why?
|
Cohort Studies | 10 | 2020 | 41791 | 0.070 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2007 | 7 | 0.070 |
Why?
|
Technology, Radiologic | 1 | 2008 | 160 | 0.070 |
Why?
|
Progestins | 2 | 2006 | 302 | 0.070 |
Why?
|
Washington | 2 | 1999 | 314 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6541 | 0.070 |
Why?
|
Head | 2 | 2010 | 927 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15939 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4526 | 0.070 |
Why?
|
Methyl Green | 1 | 2006 | 6 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2889 | 0.070 |
Why?
|
Macrophages | 2 | 2020 | 5796 | 0.070 |
Why?
|
Diet, Reducing | 1 | 2010 | 487 | 0.070 |
Why?
|
Unsafe Sex | 1 | 2008 | 239 | 0.070 |
Why?
|
Aquaporin 4 | 1 | 2007 | 161 | 0.070 |
Why?
|
Epithelial Cells | 4 | 2021 | 3692 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2955 | 0.070 |
Why?
|
Retinopathy of Prematurity | 1 | 2011 | 449 | 0.070 |
Why?
|
Ferrets | 2 | 2018 | 181 | 0.070 |
Why?
|
Specimen Handling | 1 | 2011 | 707 | 0.070 |
Why?
|
Cerebral Ventricles | 1 | 2008 | 550 | 0.070 |
Why?
|
Professional Practice | 1 | 2008 | 314 | 0.060 |
Why?
|
Inclusion Bodies | 2 | 2023 | 279 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3930 | 0.060 |
Why?
|
Urinary Incontinence | 1 | 2010 | 496 | 0.060 |
Why?
|
Cicatrix | 2 | 2023 | 799 | 0.060 |
Why?
|
Ovariectomy | 1 | 2008 | 615 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 1114 | 0.060 |
Why?
|
Twins | 1 | 2007 | 339 | 0.060 |
Why?
|
Proteomics | 2 | 2020 | 3906 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 5443 | 0.060 |
Why?
|
Time Factors | 8 | 2016 | 40267 | 0.060 |
Why?
|
Gene Expression | 2 | 2023 | 7595 | 0.060 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6856 | 0.060 |
Why?
|
Microtubules | 1 | 2011 | 1073 | 0.060 |
Why?
|
Young Adult | 5 | 2023 | 60048 | 0.060 |
Why?
|
Radiology Department, Hospital | 1 | 2009 | 409 | 0.060 |
Why?
|
beta-Defensins | 1 | 2005 | 59 | 0.060 |
Why?
|
Mesothelioma, Cystic | 1 | 2004 | 4 | 0.060 |
Why?
|
Cell Movement | 4 | 2018 | 5214 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3859 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2021 | 1837 | 0.060 |
Why?
|
Hypotrichosis | 1 | 2024 | 7 | 0.060 |
Why?
|
Enteric Nervous System | 1 | 2007 | 213 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2017 | 3612 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3326 | 0.060 |
Why?
|
Behavior Therapy | 1 | 2010 | 885 | 0.060 |
Why?
|
Acanthosis Nigricans | 1 | 2004 | 47 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1438 | 0.060 |
Why?
|
Flavonoids | 1 | 2007 | 447 | 0.060 |
Why?
|
Keratins | 2 | 2023 | 502 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7599 | 0.060 |
Why?
|
Anthropometry | 1 | 2009 | 1343 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2022 | 12801 | 0.060 |
Why?
|
Sterilization, Tubal | 2 | 2016 | 78 | 0.060 |
Why?
|
United States | 9 | 2021 | 73144 | 0.060 |
Why?
|
Foot Deformities, Congenital | 1 | 2024 | 59 | 0.060 |
Why?
|
Carcinoma, Verrucous | 1 | 2004 | 26 | 0.060 |
Why?
|
Prognosis | 7 | 2019 | 30020 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 356 | 0.060 |
Why?
|
Coloring Agents | 1 | 2006 | 563 | 0.060 |
Why?
|
Mullerian Ducts | 1 | 2005 | 203 | 0.060 |
Why?
|
Odds Ratio | 2 | 2014 | 9681 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5947 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1883 | 0.060 |
Why?
|
DNA, Viral | 3 | 2010 | 2205 | 0.060 |
Why?
|
Health Care Costs | 1 | 1997 | 3267 | 0.060 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2003 | 23 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 244 | 0.060 |
Why?
|
Neurotransmitter Agents | 1 | 2007 | 665 | 0.060 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1666 | 0.050 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2003 | 51 | 0.050 |
Why?
|
Body Fluids | 2 | 2002 | 321 | 0.050 |
Why?
|
Gonadotropins | 1 | 2004 | 241 | 0.050 |
Why?
|
Heart | 2 | 2021 | 4449 | 0.050 |
Why?
|
Caffeine | 1 | 2008 | 702 | 0.050 |
Why?
|
Vertigo | 1 | 2005 | 205 | 0.050 |
Why?
|
Plasma Cells | 1 | 2006 | 599 | 0.050 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 169 | 0.050 |
Why?
|
Societies, Medical | 3 | 2021 | 3960 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1516 | 0.050 |
Why?
|
Infant | 7 | 2022 | 36512 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3520 | 0.050 |
Why?
|
Signal Transduction | 4 | 2016 | 23629 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2126 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2004 | 473 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4740 | 0.050 |
Why?
|
Sexually Transmitted Diseases | 1 | 2008 | 666 | 0.050 |
Why?
|
Ovulation Induction | 1 | 2004 | 277 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2002 | 13576 | 0.050 |
Why?
|
Macaca mulatta | 2 | 2020 | 2361 | 0.050 |
Why?
|
Cell Differentiation | 5 | 2014 | 11659 | 0.050 |
Why?
|
Cyclin E | 1 | 2022 | 156 | 0.050 |
Why?
|
Sacrum | 1 | 2024 | 275 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2005 | 441 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2011 | 1891 | 0.050 |
Why?
|
Microtomy | 1 | 2002 | 44 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3826 | 0.050 |
Why?
|
DNA-Binding Proteins | 5 | 2013 | 9618 | 0.050 |
Why?
|
Genes, Wilms Tumor | 1 | 2002 | 92 | 0.050 |
Why?
|
Neocortex | 1 | 2006 | 417 | 0.050 |
Why?
|
Neuropeptides | 1 | 2007 | 950 | 0.050 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2002 | 38 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2004 | 239 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2016 | 7885 | 0.050 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7453 | 0.050 |
Why?
|
Vulvar Neoplasms | 1 | 2004 | 266 | 0.050 |
Why?
|
Albumins | 1 | 2004 | 577 | 0.050 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 756 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2021 | 75 | 0.050 |
Why?
|
Complement Inactivating Agents | 1 | 2021 | 53 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2006 | 1078 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2024 | 855 | 0.050 |
Why?
|
Animals | 15 | 2020 | 169322 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2819 | 0.040 |
Why?
|
Cytomegalovirus Infections | 1 | 2007 | 839 | 0.040 |
Why?
|
Mutation | 6 | 2019 | 30230 | 0.040 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1249 | 0.040 |
Why?
|
Child | 8 | 2023 | 80894 | 0.040 |
Why?
|
Child, Preschool | 7 | 2018 | 42654 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2018 | 2695 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2002 | 1866 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 131 | 0.040 |
Why?
|
Homosexuality, Male | 1 | 2008 | 1345 | 0.040 |
Why?
|
Motivation | 1 | 2010 | 2029 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1317 | 0.040 |
Why?
|
Epithelium | 1 | 2005 | 1609 | 0.040 |
Why?
|
Jejunal Neoplasms | 1 | 2000 | 20 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2007 | 1360 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4941 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 710 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2002 | 328 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2014 | 10464 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2023 | 678 | 0.040 |
Why?
|
Chromosome Deletion | 2 | 2006 | 1390 | 0.040 |
Why?
|
Adolescent | 6 | 2018 | 89182 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2019 | 40 | 0.040 |
Why?
|
Video Recording | 1 | 2005 | 974 | 0.040 |
Why?
|
Algorithms | 3 | 2016 | 14154 | 0.040 |
Why?
|
Genes, myc | 1 | 2000 | 391 | 0.040 |
Why?
|
Chondrosarcoma | 1 | 2002 | 306 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 21544 | 0.040 |
Why?
|
Colonic Polyps | 1 | 2004 | 557 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1133 | 0.040 |
Why?
|
Larva | 1 | 2001 | 514 | 0.040 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2020 | 93 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3743 | 0.040 |
Why?
|
Colectomy | 1 | 2004 | 695 | 0.040 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 1999 | 111 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2010 | 4940 | 0.040 |
Why?
|
Weight Loss | 1 | 2010 | 2715 | 0.040 |
Why?
|
Breast Feeding | 1 | 2007 | 1364 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 718 | 0.040 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2001 | 238 | 0.040 |
Why?
|
Salts | 2 | 1995 | 61 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1999 | 420 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
Menopause | 2 | 2016 | 1653 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 387 | 0.040 |
Why?
|
Online Systems | 1 | 2019 | 182 | 0.040 |
Why?
|
Ubiquitin | 1 | 2023 | 843 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 665 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1105 | 0.040 |
Why?
|
Informed Consent | 1 | 2005 | 1010 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1905 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1118 | 0.040 |
Why?
|
Haplotypes | 1 | 2024 | 2724 | 0.040 |
Why?
|
Heparitin Sulfate | 1 | 1999 | 224 | 0.040 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1999 | 248 | 0.040 |
Why?
|
Peritoneal Neoplasms | 1 | 2004 | 715 | 0.040 |
Why?
|
Brain Injuries | 1 | 2010 | 2059 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3985 | 0.040 |
Why?
|
Multivariate Analysis | 5 | 2012 | 12092 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2180 | 0.040 |
Why?
|
Risk Assessment | 8 | 2013 | 24316 | 0.040 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2001 | 342 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36849 | 0.040 |
Why?
|
Narcotics | 1 | 1999 | 334 | 0.040 |
Why?
|
Viral Load | 2 | 2021 | 3398 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 584 | 0.040 |
Why?
|
DNA Primers | 2 | 2007 | 2823 | 0.040 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2013 | 526 | 0.040 |
Why?
|
Platelet Activation | 1 | 2020 | 644 | 0.030 |
Why?
|
Methadone | 1 | 1999 | 317 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3666 | 0.030 |
Why?
|
Mice, Transgenic | 4 | 2012 | 9563 | 0.030 |
Why?
|
Oxidative Stress | 3 | 2016 | 3139 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1082 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2011 | 17132 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2004 | 1302 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2002 | 1034 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1966 | 0.030 |
Why?
|
Leg | 1 | 2001 | 1088 | 0.030 |
Why?
|
Organizational Policy | 1 | 1998 | 434 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1614 | 0.030 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2016 | 35 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1094 | 0.030 |
Why?
|
Boston | 2 | 2009 | 9371 | 0.030 |
Why?
|
Proteoglycans | 1 | 1999 | 807 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 425 | 0.030 |
Why?
|
Mice | 10 | 2015 | 82004 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19019 | 0.030 |
Why?
|
Follow-Up Studies | 6 | 2012 | 39405 | 0.030 |
Why?
|
Disease Progression | 3 | 2010 | 13646 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17626 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 782 | 0.030 |
Why?
|
Growth Plate | 1 | 2017 | 276 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1090 | 0.030 |
Why?
|
Base Sequence | 4 | 2007 | 12421 | 0.030 |
Why?
|
Viral Structural Proteins | 1 | 1995 | 93 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4049 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1995 | 326 | 0.030 |
Why?
|
Femur | 1 | 2001 | 1311 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1139 | 0.030 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1994 | 30 | 0.030 |
Why?
|
Patient Compliance | 2 | 2010 | 2693 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2006 | 419 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1255 | 0.030 |
Why?
|
Electrolytes | 1 | 1995 | 278 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2204 | 0.030 |
Why?
|
Regression Analysis | 2 | 2009 | 6350 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2709 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2117 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1758 | 0.030 |
Why?
|
Cell Division | 2 | 2015 | 4478 | 0.030 |
Why?
|
Pedigree | 2 | 2018 | 4545 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 2016 | 562 | 0.030 |
Why?
|
Cyclin B | 1 | 2014 | 104 | 0.030 |
Why?
|
Trophoblasts | 1 | 2015 | 223 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2015 | 1056 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2661 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2247 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 1998 | 1155 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2842 | 0.030 |
Why?
|
Genes, Viral | 1 | 1995 | 655 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1619 | 0.030 |
Why?
|
Menarche | 1 | 2016 | 538 | 0.030 |
Why?
|
Adenoma | 1 | 2004 | 2163 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3712 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 504 | 0.030 |
Why?
|
Fibronectins | 1 | 2017 | 724 | 0.030 |
Why?
|
Nephrectomy | 1 | 2018 | 949 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 462 | 0.030 |
Why?
|
HIV Protease | 1 | 2013 | 98 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2884 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1748 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2008 | 4339 | 0.030 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
Apoptosis | 3 | 2018 | 9506 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2011 | 1748 | 0.030 |
Why?
|
Lymphoma | 1 | 2002 | 1907 | 0.030 |
Why?
|
DNA | 2 | 1997 | 7211 | 0.030 |
Why?
|
Diet | 2 | 2007 | 8097 | 0.030 |
Why?
|
Cell Line | 3 | 2015 | 15593 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2015 | 552 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1525 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2004 | 1929 | 0.020 |
Why?
|
Postnatal Care | 1 | 2014 | 273 | 0.020 |
Why?
|
Hypertrophy | 1 | 2014 | 562 | 0.020 |
Why?
|
Viral Regulatory and Accessory Proteins | 3 | 1998 | 148 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2002 | 1177 | 0.020 |
Why?
|
Osteoblasts | 1 | 1997 | 1153 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2004 | 5151 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 997 | 0.020 |
Why?
|
Adenoviridae | 1 | 2015 | 1093 | 0.020 |
Why?
|
Ubiquitination | 1 | 2016 | 1011 | 0.020 |
Why?
|
Germany | 1 | 2013 | 882 | 0.020 |
Why?
|
Drug Utilization | 1 | 1997 | 1191 | 0.020 |
Why?
|
Menstruation Disturbances | 1 | 1992 | 143 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2013 | 628 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7242 | 0.020 |
Why?
|
Parvoviridae Infections | 1 | 2010 | 39 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4785 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4647 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2448 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2015 | 2177 | 0.020 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2010 | 23 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2417 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4175 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 317 | 0.020 |
Why?
|
Thermodynamics | 3 | 1998 | 590 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 3436 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 610 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 297 | 0.020 |
Why?
|
Age Factors | 3 | 2016 | 18472 | 0.020 |
Why?
|
Cystadenocarcinoma | 1 | 2009 | 54 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2016 | 1209 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 408 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2004 | 4069 | 0.020 |
Why?
|
Ureaplasma Infections | 1 | 2009 | 25 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 251 | 0.020 |
Why?
|
Twins, Dizygotic | 1 | 2010 | 236 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
Child Development | 2 | 2012 | 2334 | 0.020 |
Why?
|
Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
Calcinosis | 1 | 2018 | 1482 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4286 | 0.020 |
Why?
|
Guideline Adherence | 1 | 1999 | 2240 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1197 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2001 | 2565 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2008 | 89 | 0.020 |
Why?
|
Fetofetal Transfusion | 1 | 2010 | 116 | 0.020 |
Why?
|
San Francisco | 1 | 2008 | 166 | 0.020 |
Why?
|
Cephalometry | 1 | 2010 | 380 | 0.020 |
Why?
|
Ligands | 1 | 1995 | 3283 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3587 | 0.020 |
Why?
|
Carboplatin | 1 | 2011 | 799 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 1999 | 161 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 13082 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1990 | 0.020 |
Why?
|
Inclusion Bodies, Viral | 1 | 2007 | 45 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2008 | 240 | 0.020 |
Why?
|
Abortion, Eugenic | 1 | 2007 | 39 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2909 | 0.020 |
Why?
|
Protein Binding | 2 | 2017 | 9346 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2011 | 618 | 0.020 |
Why?
|
Bone and Bones | 2 | 2014 | 2588 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2038 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3728 | 0.020 |
Why?
|
Inpatients | 1 | 1998 | 2569 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9380 | 0.020 |
Why?
|
Aborted Fetus | 1 | 2006 | 11 | 0.020 |
Why?
|
Heart Failure | 1 | 2010 | 11860 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1997 | 2784 | 0.020 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2006 | 127 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3411 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2934 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 1997 | 1946 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 1642 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 65365 | 0.020 |
Why?
|
Kidney Tubules | 1 | 2007 | 448 | 0.020 |
Why?
|
Infant Mortality | 1 | 2010 | 757 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2461 | 0.020 |
Why?
|
Hospitalization | 2 | 1997 | 10844 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2008 | 572 | 0.010 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4774 | 0.010 |
Why?
|
Viral Proteins | 3 | 1998 | 1802 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5800 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1999 | 2188 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 4250 | 0.010 |
Why?
|
Self Concept | 1 | 2010 | 1047 | 0.010 |
Why?
|
Fetal Organ Maturity | 1 | 2004 | 83 | 0.010 |
Why?
|
Bacteremia | 1 | 2011 | 985 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2727 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3811 | 0.010 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2010 | 523 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2931 | 0.010 |
Why?
|
Metaplasia | 1 | 2005 | 326 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5916 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1999 | 3620 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1119 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5033 | 0.010 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 139 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 875 | 0.010 |
Why?
|
Coffee | 1 | 2008 | 597 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1135 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11914 | 0.010 |
Why?
|
Maternal Exposure | 1 | 2010 | 1079 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 952 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 2007 | 754 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
Apolipoproteins D | 1 | 2002 | 14 | 0.010 |
Why?
|
Models, Chemical | 2 | 1995 | 611 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2836 | 0.010 |
Why?
|
Prevalence | 2 | 2010 | 15868 | 0.010 |
Why?
|
Nasal Bone | 1 | 2002 | 58 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2008 | 3101 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 2002 | 189 | 0.010 |
Why?
|
Hernia, Inguinal | 1 | 2004 | 215 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12775 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4419 | 0.010 |
Why?
|
T-Box Domain Proteins | 1 | 2004 | 473 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 2002 | 108 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1640 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11220 | 0.010 |
Why?
|
Cell Death | 1 | 2006 | 1681 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2007 | 808 | 0.010 |
Why?
|
Embryo Transfer | 1 | 2004 | 527 | 0.010 |
Why?
|
Proteins | 1 | 1995 | 6006 | 0.010 |
Why?
|
Parents | 1 | 2014 | 3596 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2007 | 14481 | 0.010 |
Why?
|
Neuroglia | 1 | 2006 | 960 | 0.010 |
Why?
|
HIV Infections | 2 | 2008 | 17575 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 594 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 2002 | 246 | 0.010 |
Why?
|
Salivary Gland Neoplasms | 1 | 2004 | 306 | 0.010 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 1999 | 69 | 0.010 |
Why?
|
Nose Neoplasms | 1 | 2002 | 250 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5758 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2146 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4056 | 0.010 |
Why?
|
Syndrome | 1 | 2006 | 3275 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3794 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 1998 | 33 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2482 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2673 | 0.010 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1999 | 275 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2007 | 2887 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2004 | 977 | 0.010 |
Why?
|
Static Electricity | 1 | 1998 | 261 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 1999 | 26373 | 0.010 |
Why?
|
Rhode Island | 1 | 1998 | 353 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 2000 | 253 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1135 | 0.010 |
Why?
|
Risk | 1 | 2009 | 9635 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2010 | 3443 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 1992 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1997 | 370 | 0.010 |
Why?
|
Colonoscopy | 1 | 2004 | 1412 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2708 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5335 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1975 | 58 | 0.010 |
Why?
|
Intercalating Agents | 1 | 1995 | 33 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6238 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1229 | 0.010 |
Why?
|
Karyotyping | 1 | 1997 | 1173 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2004 | 3164 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5099 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6084 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1999 | 628 | 0.010 |
Why?
|
Bacteriophage lambda | 1 | 1994 | 142 | 0.010 |
Why?
|
Electrochemistry | 1 | 1994 | 146 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1994 | 167 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1998 | 2487 | 0.010 |
Why?
|
Computer Graphics | 1 | 1995 | 338 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1999 | 2106 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4584 | 0.010 |
Why?
|
Sterilization, Reproductive | 1 | 1992 | 24 | 0.010 |
Why?
|
Vasectomy | 1 | 1992 | 52 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2524 | 0.010 |
Why?
|
Mammography | 1 | 2002 | 2434 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1997 | 6132 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10117 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4622 | 0.000 |
Why?
|
Alleles | 1 | 1999 | 6892 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 2004 | 4360 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10776 | 0.000 |
Why?
|
Indoles | 1 | 1995 | 1825 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10266 | 0.000 |
Why?
|
Radiography | 1 | 1997 | 6993 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13425 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1999 | 12457 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22355 | 0.000 |
Why?
|
Aging | 1 | 2004 | 8764 | 0.000 |
Why?
|
Length of Stay | 1 | 1998 | 6516 | 0.000 |
Why?
|
Models, Molecular | 1 | 1994 | 5408 | 0.000 |
Why?
|
Genotype | 1 | 1997 | 13038 | 0.000 |
Why?
|
Models, Biological | 1 | 1998 | 9494 | 0.000 |
Why?
|